TAS2R14
ENSG00000212127
Target class
GPCR
Chromosome
12
- Chemical probe available
- No
- Target name
- TAS2R14
- Gene name
- Taste 2 receptor member 14
- Gene symbol
- TAS2R14
- Protein name
- Taste receptor type 2 member 14 (T2R14) (Taste receptor family B member 1) (TRB1)
- T2R14
- TRB1
- Gene biotype
- Protein coding
- Gene family
- Taste 2 receptors
- Target class
- GPCR
- Target type
- Human gene
- Tissues expressed in
- 51
- Highest tissue expression
- 11.43
- Tissue specificity (Gini)
- 0.347
- Tissue specificity (tau)
- 0.726
- KEGG gene identifiers
- hsa:50840
- Protein interaction confidence
- 0.789667
- Protein interaction partners
- 3
- R-HSA-418594
- R-HSA-420499
- R-HSA-9717207
- End position
- 11171573
- Start position
- 10937408
- Chromosome
- 12
- Strand
- Reverse
- Membrane
- Multi-pass membrane protein .
- PubMed 38600377
- PubMed 38776963
- Tissue specificity (tau)
- 0.726044
- Expression inequality (Gini)
- 0.347357
Expression in transcripts per million
- Brain - Cerebellar Hemisphere
- 11.43
- Brain - Cerebellum
- 11.05
- Ovary
- 7.4
- Uterus
- 6.61
- Pituitary
- 6.4
Expression in transcripts per million
- Brain - Cerebellar Hemisphere11.43
- Brain - Cerebellum11.05
- Ovary7.4
- Uterus6.61
- Pituitary6.4
- Nerve - Tibial6.11
- Cervix - Endocervix6.08
- Thyroid5.91
- Cervix - Ectocervix5.7
- Fallopian Tube5.59
- Brain - Spinal cord (cervical c-1)4.4
- Prostate4.22
- Colon - Sigmoid3.93
- Bladder3.71
- Vagina3.7
- Esophagus - Gastroesophageal Junction3.63
- Artery - Tibial3.61
- Spleen3.52
- Artery - Aorta3.29
- Artery - Coronary3.28
- Lung3.28
- Esophagus - Muscularis3.26
- Small Intestine - Terminal Ileum3.23
- Minor Salivary Gland2.93
- Cells - EBV-transformed lymphocytes2.93
And 29 more, listed on the interactive page.
- GO:0001580
- GO:0007186
- GO:0005886
- GO:0016020
- GO:0008527
- GO:0033038
Related records
Trials (931)
- "The Once A Day Protease Inhibitor Regimens"
- 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
- A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
- A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
- A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C
- A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
- A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
- A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
- A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
- A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
- A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
- A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder
- A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs
- A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat
- A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers
- A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
- A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
- A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study
Drugs (13)
- Flufenamic acid
- Genistein
- Luteolin
- Parthenolide
- Quinine
- Resveratrol
- Ritonavir
- Santonin
- Silibinin
- Silybin A
- Taurolithocholic acid
- Tributyrin
- Vanillin